To maintain iron homoeostasis, the iron regulatory hormone hepcidin is tightly controlled by BMP-Smad signalling pathway, but the physiological role of Smad7 in hepcidin regulation remains elusive. We generated and characterized hepatocytespecific Smad7 knockout mice (Smad7 Alb/Alb ), which showed decreased serum iron, tissue iron, haemoglobin concentration, up-regulated hepcidin and increased phosphor-Smad1/5/8 levels in both isolated primary hepatocytes and liver tissues. 
Perturbations in hepcidin expression can lead to a variety of iron-related disorders. For example, reduced hepcidin level causes iron overload in hereditary haemochromatosis (HH) and iron-loading anaemia, which is induced by ineffective erythropoiesis. 4 In HH types I, II and III, mutations either in the hepcidin-encoding gene HAMP or in genes that encode hepcidin regulators can reduce the expression of hepcidin, thereby increasing duodenal iron absorption and causing clinical iron overload. [5] [6] [7] In contrast, increased hepcidin expression causes iron restriction in a variety of inflammatory conditions, including autoimmune disease, critical illness, certain types of cancers and chronic kidney disease. 8 Therefore, considerable effort has been devoted to developing agents that target hepcidin and/or its regulators in order to develop novel therapeutic strategies for treating iron-related disorders. 9 In addition, hepcidin and hepcidin agonists can exert a protective effect on the liver, heart and other vital organs by redistributing iron into macrophages in the liver and spleen. Thus, given the high therapeutic potential of hepcidin, understanding how hepcidin is regulated in vivo is essential.
In hepatocytes, hepcidin expression is regulated by the BMPSmad signalling pathway. Binding of BMP ligands (eg BMP6) to BMP receptors on the surface of hepatocytes triggers the downstream phosphorylation of Smad proteins. 10, 11 Under dietary iron stimulation, hepatic BMP6 triggers the phosphorylation of Smad1/5/8, together with Smad4, to translocate to the nucleus, where they activates hepcidin expression. 12 Therefore, both Bmp6-deficient mice and mice with liver-specific Smad4 deletion have reduced hepcidin expression and develop an severe iron-overload phenotype. 12, 13 Results obtained from studying patients with HH types I, II or IIItogether with their corresponding genetic mouse models-support the notion that defective BMP-Smad signalling leads to hepcidin insufficiency. 6, 7, [14] [15] [16] [17] Smad7 is a negative regulators of BMP-Smad signalling, and the function of Smad7 protein in iron metabolism is poorly understood, although a growing body of in vitro evidence supports the notion that inhibitory Smads regulate hepcidin expression. 18, 19 Based on a genomewide liver transcription profiling study, the expression of Smad7 was found to be up-regulated by iron-enriched diet. 20 However, whether-and how-the Smad7 regulates dietary iron intake and hepcidin expression in the liver is currently unknown. Therefore, in this study, we generated and characterized a hepatocyte-specific
Smad7-knockout mouse model to investigate the physiological role of Smad7 in regulating iron metabolism.
| MATERIALS AND METHODS

| Animals and treatments
Conditional Smad7-floxed 21 mice were backcrossed with wild-type C57BL/6 mice (SLRC Laboratory Animal Co., Ltd., Shanghai, China)
for at least seven generations, then crossed with albumin-Cre (Alb) transgenic mice (on a C57BL/6 background) to obtain hepatocytespecific Smad7-knockout (Smad7
Alb/Alb ) mice. The Smad7-knockout mice used in this study were 8 week old of littermates. Hfe À/À mice were kindly provided by Dr. Nancy C. Andrews, 22 and Smad4 Serum iron (SI) and unsaturated iron-binding capacity (UIBC) were measured using a commercially available colorimetry-based detection kit (Pointe Scientific). Total iron-binding capacity (TIBC) and transferrin saturation (TS) were calculated from SI and UIBC as follows: TIBC = SI + UIBC and TS = (SI/TIBC 9 100). Tissue non-haem iron concentration was measured as previously described. 24 
| Ferroportin immunohistochemistry
Intestinal ferroportin detection using immunohistochemistry and Perls' Prussian blue iron staining was performed as previously described. 23 
| Isolation and culture of primary hepatocyte
Primary hepatocytes were isolated as previously described, 25 
| RNA extraction and real-time PCR analysis
RNA extraction and real-time PCR analysis of gene expression were performed as previously described. 26 Relative expression was normalized to internal control b-actin. The primer sequences are listed in Table S1 .
| RNA-seq data analysis
Eight-week-old female Smad7 flox/flox and Smad7 Alb/Alb mice were fed an iron-rich diet for 3 days. Total RNA was then isolated from the livers (3 mice per genotype), and RNA sequencing libraries were generated using the TruSeq RNA Sample Preparation Kit (Illumina). The Illumina HiSeq 2000 platform was used with 100-bp paired-end reads in accordance with the manufacturer's instructions. RNA-seq reads were mapped to the mouse reference genome (mm9, NCBI build 37) using TopHat. 27 Only uniquely aligned reads were used for gene and exon quantification. The Cufflinks tool was used to quantify isoform expression. 28 Genes that were significantly up-regulated (q < 0.05) are listed in Table S2 . These genes were then mapped to signalling pathways using the KEGG pathway mapping tool (http:// www.genome.jp/kegg/tool/map_pathway1.html).
| Statistical analysis
All summary data are presented as the mean AE SD. The Student's t test was used to compare two groups. For multiple group comparisons, we used an ANOVA followed by Tukey's post hoc test. If data did not meet the assumption of homogeneity of variance (Bartlett's test), log-transformed values were used in ANOVA. Differences were considered significant if P < .05. Statistical analyses were performed using R (http://www.r-project.org). Figure 2F ).
An analysis of serum samples revealed that Smad7
Alb/Alb mice have decreased serum iron (SI) and transferrin saturation (TS) levels ( 
| Smad7
Alb/Alb mice fed an iron-rich diet had up-regulated expressions of Smad6, Fst and Bambi
The expression of Smad7 has been linked to dietary iron. 19, 20, 30 We thus have been suggested that feeding Smad7 Alb/Alb mice with AN ET AL.
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an iron-rich diet might induce a more robust phenotype.
According to the report, the hepcidin level reached to its peak at the 3rd day of iron-rich diet treatment. 30 We therefore choose a 3-day iron-rich diet treatment for the following experiments.
Although iron-challenged Smad7 Alb/Alb mice had considerably higher liver non-haem iron concentrations compared with Smad7
Alb/ Alb mice that were fed a normal diet, these mice still had a lower liver non-haem iron concentration compared with iron-challenged Smad7 
Smad7
Alb/Alb mice ( Figure 3F ). These data suggest other factors could compensate Smad7's function in repressing hepcidin expression.
To identify these potential factors, we performed RNA-seq analysis and examined which genes were differentially expressed in the liver between Smad7 Alb/Alb mice and Smad7 flox/flox mice under ironrich dietary condition. A total of 52 genes were significantly up-regulated in Smad7 Alb/Alb mice (q < 0.05) and were selected for further analysis; these 52 genes are listed in Table S2 . The genes were mapped to signalling pathways using the KEGG pathway mapping, and the pathways with ≥5 hits are summarized in Table 2 ; all pathways with ≥3 hits are summarized in Table S3 .
Among the top-rated pathways (Table 2) , metabolic or longevity regulating pathways are not typical signal transduction Bambi interacts with membrane BMP receptors to inhibit BMP signal transduction, 31 and Smad6 inhibits the phosphorylation of Smad proteins. Fst encoding protein Follistatin binds to activin and BMPs, thereby blocking downstream signalling. 32 Based on these functions, we investigated whether these proteins played a role in limiting iron-induced hepcidin expression in the absence of Smad7.
| Smad6, Bambi and Fst are differentially controlled by the iron-BMP-Smad pathway
Because we found no detectable change in phosphor-Smad2/3 levels ( Figure 3D ) or activin expression ( Figure S4 ) in iron-challenged
Smad7
Alb/Alb mice, we tested whether the BMP6-Smad1/5/8 pathway controls these putative negative regulators of hepcidin. Accordingly, we measured the mRNA levels of Smad6, Bambi and Fst in Table S2 . Full list of pathways with hits ≥ 3 genes was summarized in Table S3 . Genes were mapped into pathways using KEGG pathway mapping. 
| DISCUSSION
Hepcidin, a liver-derived antimicrobial peptide, is a key regulator of iron homoeostasis and anaemia of inflammation. At the mechanistic level, intracellular iron sequestration is mediated by the hepcidininduced internalization and degradation of ferroportin, the only iron exporter identified to date. 3 The hepcidin-ferroportin axis is therefore a promising therapeutic target for treating many iron disorders, including haemochromatosis, b-thalassaemia, anaemia of chronic disease and iron-refractory iron deficiency anaemia. exacerbated liver injury 34 and altered immune cell responses. 35 To investigate the physiological role of Smad7 in regulating both hepcidin expression and iron metabolism, we generated hepatocyte-specific Smad7-knockout (Smad7 and increased serum levels of AST and ALT. However, we did not observe any liver damage as measured by serum AST and ALT (Figure S6) . The difference between 2 studies could be attributed to several aspects. First, the genetic background differs. In our study, 
Smad7
Alb/Alb mice were backcrossed with C57BL/6 for at least 7 generations, whereas Zhu et al used a mixed background without any backcrossing. Second, the age of the mice differs. We used 8-weekold mice, whereas they used 10~12-week-old mice.
Both liver tissue and primary hepatocytes obtained from Sma- In addition, a recent study suggested that Tmprss6 plays a key role in erythroferrone-mediated hepcidin suppression. 39 In contrast, hepatic expression of Tmprss6 remains unchanged in our Smad7
Alb/Alb mice ( Figure S3 ). Taken together, these data indicate that Smad7 together with other hepcidin-negative regulators plays an essential role in maintaining iron homoeostasis.
Smad7 expression is up-regulated in mice fed an iron-rich diet and down-regulated in mice fed an iron-deficient diet. 20 Given its role as a negative regulator of hepcidin, we have been suggested 42 Iron deposition can induce oxidative stress and the nuclear translocation of Nrf2. 43 It is therefore possible that the com- 
